• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加拿大安大略省住院糖尿病患者的人口统计学、药物使用和入院特征:一项回顾性队列研究。

Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: A retrospective cohort study.

机构信息

Sinai Health System, Division of General Internal Medicine, Toronto, Ontario, Canada.

Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

PLoS One. 2024 Aug 29;19(8):e0307581. doi: 10.1371/journal.pone.0307581. eCollection 2024.

DOI:10.1371/journal.pone.0307581
PMID:39208154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11361565/
Abstract

BACKGROUND

In Canada, one in seven adults has diabetes (i.e., 2.3 million) and the lifetime risk of developing diabetes is approximately 30% by age 65. Although 30% of patients admitted to the hospital have diabetes, data from inpatient hospitalizations for patients with diabetes are lacking, both in Canada and globally.

OBJECTIVE

To validate International Classification of Diseases 10th edition Canadian version (ICD-10-CA) codes for the identification of patients with diabetes, to create a multicenter database of patients with diabetes hospitalized under internal medicine in Ontario, and to determine their baseline characteristics, medication use, and admission characteristics.

STUDY DESIGN

We created a database of people who had diabetes and were hospitalized between 2010 and 2020 at 8 hospitals in Ontario that were part of the General Medicine Inpatient Initiative (GEMINI) hospital data-sharing network. Patients who had diabetes were identified using chart review, based upon either (i) a previous physician diagnosis of diabetes, (ii) a recorded hemoglobin A1c ≥ 6.5% or (iii) outpatient prescription of a diabetes medication preceding the hospitalization. The test characteristics of ICD-10-CA codes for diabetes were evaluated. We compared baseline demographics, medication use and hospitalization details among patients with and without diabetes. For hospitalization details, we collected information on the admission diagnosis, comorbidity index, length of stay, receipt of ICU-level care, and inpatient mortality.

RESULTS

There were 384,588 admissions within the total study cohort, of which 118,987 (30.9%) had an ICD-10-CA diagnosis code of diabetes (E10.x, E11.x, E13.x, E14.x). The sensitivity and specificity of ICD-10-CA diagnostic codes was 95.9% and 98.8%, respectively. Most patients with an ICD-10-CA code for diabetes had a code for type 2 diabetes (93.9%) and a code for type 1 diabetes was rare (6.1%). The mean age was 66.4 years for patients without diabetes and 71.3 years for those with an ICD-10-CA diagnosis code for diabetes. Patients with diabetes had a higher prevalence of hypertension (64% vs. 37.9%), coronary artery disease (28.7% vs. 15.3%), heart failure (24.5% vs. 12.1%) and renal failure (33.8% vs. 17.3%) in comparison to those without diabetes. The most prevalent diabetes medications received in hospital were metformin (43%), DPP4 inhibitors (22.7%) and sulfonylureas (18.8%). The most common reason for admission among patients with diabetes was heart failure (9.0%), and among patients without diabetes was pneumonia (7.8%). Median length of stay was longer for patients with diabetes (5.5 vs. 4.5 days) and in-hospital mortality was similar between groups (6.8% with diabetes vs. 6.5% without diabetes).

IMPORTANCE

Diabetes is one of the most prevalent chronic medical conditions, affecting roughly one third of all patients hospitalized on an internal medicine ward and is associated with other comorbidities and longer hospital stays. ICD-10-CA codes were highly accurate in identifying patients with diabetes. The development of an inpatient cohort will allow for further study of in-hospital practices and outcomes among patients with diabetes.

摘要

背景

在加拿大,每七个成年人中就有一人患有糖尿病(即 230 万人),到 65 岁时,患糖尿病的终身风险约为 30%。尽管住院的患者中有 30%患有糖尿病,但加拿大和全球都缺乏糖尿病患者住院的住院数据。

目的

验证国际疾病分类第十版加拿大版(ICD-10-CA)代码,以识别糖尿病患者,创建安大略省内科住院患者的多中心数据库,并确定他们的基线特征、药物使用和入院特征。

研究设计

我们创建了一个数据库,其中包含在安大略省 8 家参与一般内科住院倡议(GEMINI)医院数据共享网络的医院于 2010 年至 2020 年期间住院的糖尿病患者。使用图表审查根据以下任何一种方法确定患有糖尿病的患者:(i)先前医生诊断为糖尿病,(ii)记录的血红蛋白 A1c≥6.5%,或(iii)住院前开具的糖尿病药物处方。评估了 ICD-10-CA 糖尿病代码的测试特征。我们比较了有和没有糖尿病的患者的基线人口统计学、药物使用和住院详细信息。对于住院详细信息,我们收集了入院诊断、合并症指数、住院时间、是否接受 ICU 级护理以及住院死亡率等信息。

结果

在总研究队列中,共有 384588 次入院,其中 118987 次(30.9%)的 ICD-10-CA 诊断代码为糖尿病(E10.x、E11.x、E13.x、E14.x)。ICD-10-CA 诊断代码的灵敏度和特异性分别为 95.9%和 98.8%。大多数患有 ICD-10-CA 糖尿病代码的患者都有 2 型糖尿病代码(93.9%),而 1 型糖尿病代码很少见(6.1%)。无糖尿病患者的平均年龄为 66.4 岁,而有 ICD-10-CA 糖尿病诊断代码的患者的平均年龄为 71.3 岁。与没有糖尿病的患者相比,患有糖尿病的患者高血压(64%比 37.9%)、冠状动脉疾病(28.7%比 15.3%)、心力衰竭(24.5%比 12.1%)和肾衰竭(33.8%比 17.3%)的患病率更高。在医院接受的最常见的糖尿病药物是二甲双胍(43%)、DPP4 抑制剂(22.7%)和磺酰脲类(18.8%)。患有糖尿病的患者最常见的入院原因是心力衰竭(9.0%),而没有糖尿病的患者最常见的入院原因是肺炎(7.8%)。患有糖尿病的患者住院时间中位数较长(5.5 天比 4.5 天),两组住院死亡率相似(6.8%患有糖尿病比 6.5%没有糖尿病)。

重要性

糖尿病是最常见的慢性疾病之一,约占内科病房住院患者的三分之一,与其他合并症和更长的住院时间有关。ICD-10-CA 代码在识别糖尿病患者方面非常准确。住院患者队列的建立将允许进一步研究糖尿病患者的住院实践和结果。

相似文献

1
Demographics, medication use, and admission characteristics of patients hospitalized with diabetes in Ontario, Canada: A retrospective cohort study.加拿大安大略省住院糖尿病患者的人口统计学、药物使用和入院特征:一项回顾性队列研究。
PLoS One. 2024 Aug 29;19(8):e0307581. doi: 10.1371/journal.pone.0307581. eCollection 2024.
2
Accuracy of ICD-10 Coding System for Identifying Comorbidities and Infectious Conditions Using Data from a Thai University Hospital Administrative Database.使用泰国大学医院行政数据库数据的ICD-10编码系统识别合并症和感染性疾病的准确性
J Med Assoc Thai. 2016 Apr;99(4):368-73.
3
Characterizing medical patients with delirium: A cohort study comparing ICD-10 codes and a validated chart review method.描述伴有意识混乱的医学患者特征:一项比较 ICD-10 编码和已验证的图表审查方法的队列研究。
PLoS One. 2024 May 13;19(5):e0302888. doi: 10.1371/journal.pone.0302888. eCollection 2024.
4
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.1型或2型糖尿病患者血糖控制与糖尿病相关住院费用之间的关系。
J Manag Care Pharm. 2010 May;16(4):264-75. doi: 10.18553/jmcp.2010.16.4.264.
5
Getting a grippe on severity: a retrospective comparison of influenza-related hospitalizations and deaths captured in reportable disease and administrative data sources in Ontario, Canada.把握严重程度:加拿大安大略省报告疾病和行政数据来源中捕获的流感相关住院和死亡的回顾性比较。
BMC Public Health. 2019 May 14;19(1):567. doi: 10.1186/s12889-019-6924-9.
6
Community-based care for the specialized management of heart failure: an evidence-based analysis.基于社区的心力衰竭专科管理:一项循证分析
Ont Health Technol Assess Ser. 2009;9(17):1-42. Epub 2009 Nov 1.
7
Validation of the Diagnostic Accuracy Levels of International Classification of Diseases, 10th Revision Codes for Diabetic Ketoacidosis: A Multicentre, Cross-sectional Study of Adults.国际疾病分类第 10 版诊断准确性水平对糖尿病酮症酸中毒的验证:一项针对成年人的多中心横断面研究。
Can J Diabetes. 2024 Jun;48(4):227-232. doi: 10.1016/j.jcjd.2024.01.006. Epub 2024 Jan 21.
8
Does diabetes mellitus comorbidity affect in-hospital mortality and length of stay? Analysis of administrative data in an Italian Academic Hospital.糖尿病合并症是否会影响住院死亡率和住院时间?对一家意大利学术医院行政数据的分析。
Acta Diabetol. 2017 Dec;54(12):1081-1090. doi: 10.1007/s00592-017-1050-6. Epub 2017 Sep 15.
9
Validation of algorithms using International Classification of Diseases for the identification of herpes zoster episodes requiring hospitalization in Quebec, Canada.利用国际疾病分类算法验证加拿大魁北克地区需要住院治疗的带状疱疹发作病例。
Vaccine. 2021 Oct 1;39(41):6074-6080. doi: 10.1016/j.vaccine.2021.08.100. Epub 2021 Sep 13.
10
Validity of Hospital Codes for Obesity in Ontario, Canada.加拿大安大略省医院肥胖症代码的有效性。
Can J Diabetes. 2021 Apr;45(3):243-248.e4. doi: 10.1016/j.jcjd.2020.08.106. Epub 2020 Sep 3.

本文引用的文献

1
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2022 年美国糖尿病协会 (ADA) 和欧洲糖尿病研究协会 (EASD) 共识报告:2 型糖尿病患者高血糖管理。
Diabetes Care. 2022 Nov 1;45(11):2753-2786. doi: 10.2337/dci22-0034.
2
Nordic Health Registry-Based Research: A Review of Health Care Systems and Key Registries.基于北欧健康登记处的研究:医疗保健系统与关键登记处综述
Clin Epidemiol. 2021 Jul 19;13:533-554. doi: 10.2147/CLEP.S314959. eCollection 2021.
3
Using machine learning to predict severe hypoglycaemia in hospital.利用机器学习预测医院内严重低血糖症。
Diabetes Obes Metab. 2021 Oct;23(10):2311-2319. doi: 10.1111/dom.14472. Epub 2021 Jul 8.
4
Association of diabetes with frequency and cost of hospital admissions: a retrospective cohort study.糖尿病与住院频率和费用的关联:一项回顾性队列研究。
CMAJ Open. 2021 Apr 16;9(2):E406-E412. doi: 10.9778/cmajo.20190213. Print 2021 Apr-Jun.
5
Association of Race/Ethnicity, Gender, and Socioeconomic Status With Sodium-Glucose Cotransporter 2 Inhibitor Use Among Patients With Diabetes in the US.美国糖尿病患者中钠-葡萄糖共转运蛋白 2 抑制剂使用与种族/民族、性别和社会经济地位的关联。
JAMA Netw Open. 2021 Apr 1;4(4):e216139. doi: 10.1001/jamanetworkopen.2021.6139.
6
Assessing the quality of clinical and administrative data extracted from hospitals: the General Medicine Inpatient Initiative (GEMINI) experience.评估从医院提取的临床和行政数据的质量:综合内科住院患者倡议(GEMINI)的经验。
J Am Med Inform Assoc. 2021 Mar 1;28(3):578-587. doi: 10.1093/jamia/ocaa225.
7
Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis.糖化血红蛋白降低与心血管结局和全因死亡率的关系:一项荟萃回归分析。
J Diabetes Complications. 2020 Nov;34(11):107704. doi: 10.1016/j.jdiacomp.2020.107704. Epub 2020 Jul 31.
8
[Health-related register-based research in Denmark].[丹麦基于健康登记册的研究]
Ugeskr Laeger. 2018 Oct 22;180(43).
9
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂、胰高血糖素样肽 1 受体激动剂和二肽基肽酶 4 抑制剂与 2 型糖尿病患者全因死亡率的关联:系统评价和荟萃分析。
JAMA. 2018 Apr 17;319(15):1580-1591. doi: 10.1001/jama.2018.3024.
10
Pharmacologic Glycemic Management of Type 2 Diabetes in Adults.成人2型糖尿病的药物血糖管理
Can J Diabetes. 2018 Apr;42 Suppl 1:S88-S103. doi: 10.1016/j.jcjd.2017.10.034.